Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9330
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 9 $32,528 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $32,528 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 1% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.
The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The IDC was not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Nexplanon 68 MG implants | Defense Logistics Agency | $10,374 | |
| YF-VAX 1 dose vials | Defense Logistics Agency | $1,259 | |
| Menquadfi vial 0.5ML | Defense Logistics Agency | $1,312 | |
| Nexplanon 68 MG implants | Defense Logistics Agency | $864 | |
| Pedvaxhib vaccine vial 0.5ML | Defense Logistics Agency | $209 | |
| Mirena 52 MG systems | Defense Logistics Agency | $6,570 | |
| Exparel 266 MG/20 ML vial 20ML | Defense Logistics Agency | $10,269 | |
| YF-VAX 1 dose vials | Defense Logistics Agency | $1,114 | |
| YF-VAX 1 dose vials | Defense Logistics Agency | $557 |
Quick answers
Who was awarded contract SPE2DR25D9330?
SPE2DR25D9330 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9330 worth?
Orders under SPE2DR25D9330 have obligated $32,528. SPE2DR25D9330's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9330?
9 orders have been placed under SPE2DR25D9330, the latest on July 13, 2026.
Who can order from contract SPE2DR25D9330?
SPE2DR25D9330 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9330 competed?
The extent of competition for SPE2DR25D9330 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV